Search Results - "Agaoglu, L."

Secondary Hemophagocytic Lymphohistiocytosis Induced by Malaria Infection in a Child with Langerhans Cell Histiocytosis by Saribeyoglu, E. Tugrul, Anak, S., Agaoglu, L., Boral, O., Unuvar, A., Devecioglu, O.

“…Since the first description of infection-associated hemophagocytosis (IAHS), the list of precipitating infectious agents causing hemophagocytic syndrome has…”
Get full text

Cost-Effectiveness of Cefepime + Netilmicin or Ceftazidime + Amikacin or Meropenem Monotherapy in Febrile Neutropenic Children with Malignancy in Turkey by Agaoglu, L., Devecioglu, O., Anak, S., Karakas, Z., Yalman, N., Biner, B., Eryilmaz, E., Goksan, B., Unuvar, A., Agirbasli, H., Can, M., Bilgen, H., Gedikoglu, G.

“…Infection remains the major cause of morbidity and mortality in immuno-compromised children with malignancy. In addition, the economic impact of antibiotic…”
Get full text

Prognostic value of P-gp expression and related function in childhood acute leukemia by Karakaş, Z, Ağaoğlu, L, Erdem, S, Demirel, G Y, Arasa, M, Süzergöz, F, Deniz, G, Anak, S, Gedikoğlu, G

Get more information

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia by Cappellini, Maria Domenica, Cohen, Alan, Piga, Antonio, Bejaoui, Mohamed, Perrotta, Silverio, Agaoglu, Leyla, Aydinok, Yesim, Kattamis, Antonis, Kilinc, Yurdanur, Porter, John, Capra, Marcello, Galanello, Renzo, Fattoum, Slaheddine, Drelichman, Guillermo, Magnano, Carmelo, Verissimo, Monica, Athanassiou-Metaxa, Miranda, Giardina, Patricia, Kourakli-Symeonidis, Alexandra, Janka-Schaub, Gritta, Coates, Thomas, Vermylen, Christiane, Olivieri, Nancy, Thuret, Isabelle, Opitz, Herbert, Ressayre-Djaffer, Catherine, Marks, Peter, Alberti, Daniele

“…Deferasirox (ICL670) is a once-daily oral iron chelator developed for the treatment of chronic iron overload from blood transfusions. A comparative phase 3…”
Get full text

The molecular basis of β-thalassemia in Turkey by BASAK, A. N, ÖZCELIK, H, KIRDAR, B, ÖZER, A, TOLUN, A, AKSOY, M, AGAOGLU, L, RIDOLFI, F, ULUKUTLU, L, AKAR, N, GÜRGEY, A

“…By using oligonucleotide hybridization, restriction endonuclease analysis and direct sequencing of amplified genomic DNA, we have been able to characterize 18…”
Get full text

Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study by Gattermann, Norbert, Finelli, Carlo, Porta, Matteo Della, Fenaux, Pierre, Ganser, Arnold, Guerci-Bresler, Agnes, Schmid, Mathias, Taylor, Kerry, Vassilieff, Dominique, Habr, Dany, Domokos, Gabor, Roubert, Bernard, Rose, Christian

“…Abstract The prospective 1-year EPIC study enrolled 341 patients with myelodysplastic syndromes (MDS); although baseline iron burden was >2500 ng/mL, ∼50% were…”
Get full text

IS AML1/ETO GENE EXPRESSION A GOOD PROGNOSTIC FACTOR IN PEDIATRIC ACUTE MYELOBLASTIC LEUKEMIA? by Sarper, Nazan, Ozbek, Ugur, Agaoglu, Leyla, Ozgen, Unsal, Eryilmaz, Ertugrul, Yalman, Nevin, Anak, Sema, Devecioglu, Omer, Gedikoglu, Gunduz

“…To assess the clinical significance of AML1/ETO gene detected by nested reverse transcriptase polymerase chain reaction, the outcome of 7 patients with acute…”
Get full text

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia by Yalman, N, Sarper, N, Devecioğlu, O, Anak, S, Eryilmaz, E, Can, M, Yenilmez, H, Ağaoğlu, L, Gedikoğlu, G

“…The prognosis of relapsed acute leukemia or chronic leukemia in acute blast crisis is poor and new chemotherapeutic regimens could be useful for these…”
Get more information

wt1 gene expression in childhood acute leukemias by Ozgen, U, Anak, S, Ozbek, U, Sarper, N, Eryilmaz, E, Ağaoğlu, L, Devecioğlu, O, Yalman, N, Gedikoğlu, G

Get more information

MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report by Karakaş, Z, Ağaoğlu, L, Erdem, S, Anak, S, Hacibektaşoğlu, A, Gedikoğlu, G

Get more information

Immunologic status in children with brain tumors and the effect of therapy by KEBUDI, R, AYAN, I, DARENDELILER, E, AGAOGLU, L, EKMEKCIOGLU, S, YAGCI, T, PISKIN, S, BILGE, N

“…The cellular and humoral immunological parameters (leucocyte, granulocyte, lymphocyte, total T, T4, T8 lymphocyte counts, lymphoproliferative response to PHA…”
Get full text

Molecular basis of β-thalassemia in Turkey : detection of rare mutations by direct sequencing by AULEHLA-SCHOLZ, C, BASARAN, S, AGAOGLU, L, ARCASOY, A, HOLZGREVE, W, MINY, P, RIDOLFI, F, HORST, J

“…Using restriction endonuclease analysis, oligonucleotide hybridization, and direct sequencing of amplified genomic DNA, we characterized 11 different mutations…”
Get full text

The effect of iron deficiency anemia on the function of the immune system by Ekiz, Ceyda, Agaoglu, Leyla, Karakas, Zeynep, Gurel, Nuray, Yalcin, Işik

“…We aimed to study the effect of iron deficiency anemia (IDA) on immunity. In 32 children with IDA and 29 normal children, the percentage of T-lymphocyte…”
Get more information

Aclacinomycin-A in the treatment of childhood acute leukaemia by Gedikoğlu, G, Zülfikar, B, Anak, S, Ayan, I, Tüzün, B, Ozgenç, S, Devecioğlu, O, Ağaoğlu, L

Get more information

A study of various antibiotic combinations for the empiric treatment of neutropenic febrile children by Anak, S, Devecioğlu, O, Ağaoğlu, L, Zülfikar, B, Ayan, I, Atilgan, N, Yalman, N, Bilgen, H, Kaya, G, Gedikoğlu, G

Get more information

Long-Term Effects of Deferasirox (Exjade®, ICL670) on Serum Ferritin: Outcome of Dose Adjustments in Achieving Maintenance or Reduction in Body Iron Stores by Porter, J.B., Cohen, A., Agaoglu, L., Ganser, A., Cappellini, M.D., Maseruka, H., Glimm, E., Alberti, D.

“…During 1-year core phases of two deferasirox trials, doses were initially assigned by baseline liver iron concentration (LIC). In these regularly transfused…”
Get full text

NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia by Sirma, Sema, Agaoglu, Leyla, Yildiz, Inci, Cayli, Dilara, Horgusluoglu, Emrin, Anak, Sema, Yuksel, Lebriz, Unuvar, Aysegul, Celkan, Tiraje, Apak, Hilmi, Karakas, Zeynep, Devecioglu, Omer, Ozbek, Ugur

“…Background NAD(P)H:quinone oxidoreductase1 (NQO1) is a two‐electron reductase that detoxifies quinones derived from the oxidation of phenolic metabolites of…”
Get full text

Patient Satisfaction with Deferasirox (Exjade®, ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy by Cappellini, M.D., Bejaoui, M., Agaoglu, L., Lai, M.E., Mangiagli, A., Strauss, G., Girot, R., Opitz, H., Abetz, L., Baladi, J.F., Ressayre-Djaffer, C., Ford, J.

“…Frequent blood transfusions result in iron overload and lead to life-threatening complications and early mortality if regular chelation therapy (CT) is not…”
Get full text

Allogeneic versus autologous versus peripheral stem cell transplantation in CR1 pediatric AML patients: A single center experience by Anak, Sema, Saribeyoglu, Ebru Tugrul, Bilgen, Hülya, Unuvar, Aysegul, Karakas, Zeynep, Devecioglu, Omer, Agaoglu, Leyla, Gedikoglu, Gunduz

“…Background Treatment of childhood acute myelocytic leukemia (AML) in first remission, is still evolving. Allogeneic bone marrow transplantation (BMT) in…”
Get full text

Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration by Devecioğlu, Ömer, Biner, Betül, Karaböcüoğlu, Metin, Ünüvar, Ayşegül, Ağaoğlu, Leyla

Get full text